The Rise of ADCs: A New Era of Targeted Cancer Therapeutics

adicionou um novo artigo Health

2025-06-18 06:35:38

Antibody-drug conjugates (ADCs) represent a transformative class of oncology therapeutics, combining the precision of monoclonal antibodies with the potency of cytotoxic agents. This hybrid technology offers a novel mechanism of action—delivering chemotherapeutic payloads directly to cancer cells, reducing off-target effects, and improving treatment specificity. ADCs are now a focal point...

0 Comentários 0 Compartilhamentos 73 Visualizações 0 Anterior